📊 AXGN Key Takeaways
Investment Thesis
Despite strong revenue growth of 20.2% YoY and an impressive 74.3% gross margin, Axogen is unprofitable with negative operating income of -$7.8M and deteriorating net income that declined 57.6% YoY. The company is burning cash with negative free cash flow of -$2.9M while carrying substantial debt of $48.4M, creating significant financial strain that undermines growth quality.
AXGN Strengths
- Strong revenue growth of 20.2% YoY demonstrates market demand
- Excellent gross margin of 74.3% indicates pricing power and operational efficiency in core business
- Solid liquidity position with current ratio of 5.11x and $35.5M cash buffer
AXGN Risks
- Persistent operating losses of -$7.8M indicate inability to convert revenue growth into profitability
- Negative free cash flow of -$2.9M and operating cash flow of only $812K despite $225.2M revenue signals operational inefficiency
- High debt burden of $48.4M with negative interest coverage ratio of -3.4x creates refinancing and solvency risk
- Deteriorating net income (-57.6% YoY) and negative ROE/ROA suggest fundamental business model challenges
Key Metrics to Watch
- Path to operating profitability and timeline to positive operating margins
- Free cash flow generation and ability to service $48.4M debt without dilution
- Operating expense management as a percentage of revenue to close profitability gap
AXGN Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 5.11x current ratio provides a solid financial cushion.
AXGN Profitability Ratios
AXGN vs Healthcare Sector
How Axogen, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
AXGN Balance Sheet & Liquidity
AXGN 5-Year Financial Trend
5-Year Trend Summary: Axogen, Inc.'s revenue has grown significantly by 77% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.51 indicates the company is currently unprofitable.
AXGN Growth Metrics (YoY)
AXGN Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $48.6M | $708.0K | $0.01 |
| Q2 2025 | $47.9M | $579.0K | $0.01 |
| Q1 2025 | $41.4M | -$3.8M | $-0.08 |
| Q3 2024 | $41.3M | -$1.9M | $-0.04 |
| Q2 2024 | $38.2M | -$1.9M | $-0.04 |
| Q1 2024 | $36.7M | -$6.6M | $-0.15 |
| Q3 2023 | $37.0M | -$4.1M | $-0.10 |
| Q2 2023 | $34.5M | -$6.7M | $-0.16 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AXGN Capital Allocation
AXGN SEC Filings
Access official SEC EDGAR filings for Axogen, Inc. (CIK: 0000805928)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Mar 18, 2026 | 4 | xslF345X06/wk-form4_1773864674.xml | View → |
| Mar 18, 2026 | 4 | xslF345X06/wk-form4_1773864598.xml | View → |
| Mar 2, 2026 | 4 | xslF345X05/wk-form4_1772493414.xml | View → |
| Mar 2, 2026 | 4 | xslF345X05/wk-form4_1772493371.xml | View → |
| Mar 2, 2026 | 4 | xslF345X05/wk-form4_1772493346.xml | View → |
❓ Frequently Asked Questions about AXGN
What is the AI rating for AXGN?
Axogen, Inc. (AXGN) has an AI rating of SELL with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are AXGN's key strengths?
Strong revenue growth of 20.2% YoY demonstrates market demand. Excellent gross margin of 74.3% indicates pricing power and operational efficiency in core business.
What are the risks of investing in AXGN?
Persistent operating losses of -$7.8M indicate inability to convert revenue growth into profitability. Negative free cash flow of -$2.9M and operating cash flow of only $812K despite $225.2M revenue signals operational inefficiency.
What is AXGN's revenue and growth?
Axogen, Inc. reported revenue of $225.2M.
Does AXGN pay dividends?
Axogen, Inc. does not currently pay dividends.
Where can I find AXGN SEC filings?
Official SEC filings for Axogen, Inc. (CIK: 0000805928) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AXGN's EPS?
Axogen, Inc. has a diluted EPS of $-0.34.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.